How to Train Your Dragon 2 hits theaters this week, and as with any sequel, you know that it will have to up the ante for its Viking hero Hiccup. When we last saw him, he’d managed to convince save his father and the others from a giant dragon, losing his leg in the process. This time the danger is even greater, as a villain named Drago captures dragons and prepares for war. The reviews have been stellar: Grantland’s Wesley Morris says the humans in How to Train Your Dragon 2 are “almost more graceful than the dragons�� and the dragons could dance for Alvin Ailey;” NPR’s Bob Mondello notes that the film “took inspiration from the�first�Star Wars�trilogy ��not a bad model for breathing new life, and yes, a bit of fire, into one of Hollywood’s more nuanced animated franchises;” and the Wall Street Journal’s Joe Morgenstern calls it “a movie the world needs.” No wonder, then, that How to Train Your Dragon 2 is forecast to pull in $67 million at the box office. My only fear: Can I take my kids? Not only are battles big, but the stakes are supposed to be higher. I just hope it’s not too traumatic.
Top 5 Electric Utility Companies For 2015: Allergan Inc. (AGN)
Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the La p-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
William Ackman‘s Pershing Square Capital Management L.P. has asked a Delaware court to confirm that its recent push for a special meeting of Allergan Inc.(AGN) shareholders won’t trigger the Botox maker’s poison pill.
- [By Ben Levisohn]
Allergan (AGN) has gained 1.6% after�Valeant�(VRX) said it would improve its bid for the company.
Keurig Green Mountain�(GMCR) has gained 5.2% after�Coca-Cola�(KO) upped its stake in the company. Coca-Cola has dipped 0.1%.
- [By Garrett Cook]
Salix Pharmaceuticals (NASDAQ: SLXP) shares shot up 5.52 percent to $168.66 on report of takeover talks with Allergan. Allergan (NYSE: AGN) is set to acquire Salix Pharmaceuticals in a deal probably worth more than $10 billion, according to Dow Jones Newswires.
Best Sliver Companies To Watch In Right Now: Laboratory Corporation of America Holdings(LH)
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company in the United States. The company offers a range of testing services used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease, as well as specialty testing services. Its routine tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, HIV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company?s specialty tests and related services comprise viral load measurements, genotyping and phenotyping, and host genetic factors for managing and treating HIV infections; cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests for diagnostic genetics; oncology tests for diagnosing and monitoring certain cancers and treatments; clinical trials testing for pharmaceutical companies, which conducts clinical research trials on diag nostic assays; forensic identity testing used in criminal proceedings and parentage evaluation services, as well as testing services in reconstruction cases; allergy testing; and occupational testing for the detection of drug and alcohol abuse. Its customers include independent physicians and physician groups, hospitals, managed care organizations, governmental agencies, employers, pharmaceutical companies, and other independent clinical laboratories. The company operates a network of 51 primary laboratories and approximately 1,700 patient service centers. In addition, it delivers a co-branded electronic health records Lite solution for physician practices. The company works with university, hospital, and academic institutions, such as Duke University, The Johns Hopkins University, the University of Minnesota, and Yale University to license and commercialize new diagnostic tests. Laboratory Corporation of America Holdings was founded in 1971 and is headquartered in Burlingto n, North Carolina.
Advisors' Opinion:- [By Daniel Lauchheimer]
EXAS began their pivotal DeeP-C trial earlier this year, with 10,000 patients enrolled around the USA. Success in this trial formed a pivotal fulcrum for EXAS -- success would mean commercialization, and revenue, but failure means, well failure. In April, EXAS submitted the final module of this trial, and it reported significantly worse results than expected causing the company to sink 40%. Additionally, as reported in a detailed five part series, Seeking Alpha Contributor Alpha Exposure reported on the inflated numbers both in terms of scientific research data and market projections -- yet another reason to give investors pause before they decide to invest in EXAS. Additionally, EXAS has not formed a meaningful partnership with other molecular diagnostic companies. True, it formed a partnership with LabCorp (LH), but this partnership doesn't focus on the heart of EXAS product (and thus provide it with a measure of validation), but on a commercialization post approval.
Best Sliver Companies To Watch In Right Now: Kiwibox.com Inc (KIWB)
Kiwibox.Com, Inc. (Kiwibox), incorporated on April 19, 1988, is an early stage company. The Company owns and operates Kiwibox.com, which is a social networking Website. The Company has equipped the Website with the advertising features, which enable sponsors to self-direct their message to specific target audiences based on gender, age, geographic region, education, and interests. As of December 31, 2011, the Company generated the majority of its revenue from advertising/sponsorships. On September 30, 2011 Kiwibox.com acquired 100% interests in the social network, KWICK!! Community GmbH & Co. KG, and interest of its general partner, Kwick!! Community Beteiligungs GMBH. On March 7, 2011 the Company acquired Pixunity.DE a German photo book community.
Kiwibox.com has developed a monitoring model. The Kiwibox.com platform is equipped with technology features, which includes the private sphere configuration of users, contact blocs, anti-spam protection and intelligent self-learning user-scoring feature.
The Company competes with Facebook.com, Twitter and MySpace.com.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap stocks Kiwibox.com Inc (OTCMKTS: KIWB), Eyes on The Go Inc (OTCMKTS: AXCG) and Green Endeavors Inc (OTCMKTS: GRNE) were sinking 37.5%, 28.57% and 23.9%, respectively. Moreover, it should be mentioned that all three small cap stocks have been the subject of recent paid promotions or investor relation campaigns which have gotten them mentions in various investment newsletters or investor alerts. So are the promotional or investor relation campaigns over with for these three small caps? Here is a quick look to help you decide:
Kiwibox.com Inc (OTCMKTS: KIWB) Makes an Acquisition in Germany and Reports Surging RegistrationsSmall cap Kiwibox.com Inc owns and operates social networking sites like Kiwibox.com, a site that has over over 14 years experience as social network. On Friday, Kiwibox.com Inc sank 37.5% to $0.005 for a market cap of $3.41 million plus KIWB is down 58.3% over the past year and down 63% over the past five years according to Google Finance.
Best Sliver Companies To Watch In Right Now: Harley-Davidson Inc. (HOG)
Harley-Davidson, Inc. produces and sells heavyweight motorcycles, as well as offers motorcycle parts, accessories, and related services. It operates in two segments, Motorcycles and Related Products, and Financial Services. The Motorcycles and Related Products segment engages in the design, manufacture, and sale of primarily heavyweight cruiser and touring motorcycles primarily in North America, Europe, the Middle East, Africa, the Asia/Pacific, and Latin America. It also provides a line of motorcycle parts and accessories, including replacement parts, and mechanical and cosmetic accessories; general merchandise, such as apparel and riding gear; and related services. This segment manufactures five families of motorcycles, including Touring, Dyna, Softail, Sportster, and VRSC; and offers its products under the Harley-Davidson brand name. The Financial Services segment provides wholesale and retail financing, and insurance and insurance-related programs to the company?s deal ers and retail customers in the United States and Canada. It involves in financing and servicing wholesale inventory receivables and retail consumer loans, principally for the purchase of Harley-Davidson motorcycles. This segment?s wholesale financial services comprise floorplan and open account financing of motorcycles, and motorcycle parts and accessories to Harley-Davidson dealers; and retail financial services include installment lending for the purchase of its new and used motorcycles. This segment also offers motorcycle insurance and property/casualty insurance, as well as sells extended service contracts, gap coverage, and debt protection products to motorcycle owners. Harley-Davidson sells its products through independent dealers and distributors. The company was founded in 1903 and is based in Milwaukee, Wisconsin.
Advisors' Opinion:- [By Lisa Levin]
Harley-Davidson (NYSE: HOG) shares touched a new 52-week high of $72.56 after the company reported a rise in its first-quarter profit.
Allergan (NYSE: AGN) shares reached a new 52-week high of $164.46 on buyout offer from Valeant Pharmaceuticals International (NYSE: VRX).
- [By iStockAnalyst]
Harley-Davidson, Inc. (NYSE:HOG) benefits from an ongoing replacement cycle, with buyers returning to the motorcycle market owing to better access to credit, renewed confidence from rising home prices, and innovative and quality new products.
- [By Ben Levisohn]
Make that six days of gains for the S&P 500, after the benchmark got a big boost from Home Depot (HD), Goldman Sachs (GS), Harley-Davidson (HOG), Netflix (NFLX) and Wynn Resorts (WYNN).
- [By Matt Koppenheffer]
(On feeling comfortable lending to Harley-Davidson (NYSE: HOG ) during the financial crisis and the importance of customer loyalty): "Any company that gets its customers to tattoo ads on its chest can't be all bad."
Best Sliver Companies To Watch In Right Now: Sumitomo Mitsui Financial Group Inc(SMFG)
Sumitomo Mitsui Financial Group, Inc., through its subsidiaries, provides various banking and financial products and services in Japan, the Americas, Europe, the Middle East, Asia, and Oceania. It operates in four segments: Commercial Banking, Securities, Leasing, and Credit Card. The commercial banking segment offers various financial services, including personal bank accounts, investment trusts, pension-type insurance products, life insurance products, and housing loans to individuals; and lending, cash management, settlement, leasing, factoring, management information systems consulting, collection, and investment banking services to mid-sized companies, and small- and medium-sized enterprises. It also provides various financial services, such as loans, deposits, and settlement services, as well as loan syndication, structured finance, and nonrecourse loans to large corporations and listed companies; international banking services comprising project finance, loan syndic ation, securitization, shipping finance, global cash management services, and yen custody services; and provides services related to foreign exchange, securities, and derivatives. The Securities segment offers various financial products, including stocks, bonds, investment trusts, and variable annuity insurance; investment consultation; and administration services to individual and corporate customers. The Leasing segment offers provides leasing services, such as leasing of information and communication equipment, industrial equipment, and construction equipment, as well as aircraft leasing. The Credit Card segment provides various credit cards; and settlement and financing services primarily related to credit card transactions. Sumitomo Mitsui Financial Group, Inc. is headquartered in Tokyo, Japan.
Advisors' Opinion:- [By Jim Jubak]
Yesterday in Tokyo, the Nikkei 225 stock index (NKY:IND) closed up 3.13%. Financial and real estate stocks were the big winners. In the financial sector, Mitsubishi UFJ Financial Group (MTU) rose 5.03% and Sumitomo Mitsui Financial Group (SMFG) climbed 5.0%. (Mitsubishi UFJ Financial Group is a member of my Jubak's Picks portfolio.) In the real estate sector, Heiwa Real Estate (8803:JP) gained 4.13% and Mitsui Fudosan (8801:JP) advanced 3.31%. The yen fell against the dollar by 0.4% to 102.34 yen to the dollar.
- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Stocks in Japan climbed at the start of trade Tuesday, as U.S. dollar strength against the yen aided the export-oriented market. The Nikkei Stock Average (JP:NIK) advanced 1% to 14,431.03, and the broader Topix rose 1.5% to 1,201.63, with the greenback moving back above the 楼102 level versus Japan's currency. Among exporters, stock in Canon Inc. (JP:7751) (CAJ) rose 1.6%, Mazda Motor Corp. (JP:7261) (MZDAF) tacked on 1.5%, and Sony Corp. (JP:6758) (SNE) gained 1.4%. Banking stocks were higher ahead of the conclusion of the Bank of Japan's meeting later Tuesday, and officials are not expected to announce any changes in monetary policy. Shares of Mitsubishi UFJ Financial Group Inc. (JP:8306) (MTU) and Sumitomo Mitsui Financial Group Inc. (JP:8316) (SMFG) were each up by 1.7%.
- [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- Japanese stocks darted out of small gains and losses early Friday, with investors watching the dollar as it traded back slightly below the 102-yen level. The Nikkei Stock Average (JP:NIK) fell 0.2% to 15,142.60, and the broader Topix shed 0.2%. Financial issues were lower, in line with losses on Wall Street ahead of the November U.S. jobs report, due later Friday. In the group, Mitsubishi UFJ Financial Group Inc. (JP:8306) (MTU) shed 0.6%, and Sumitomo Mitsui Financial Group Inc. (JP:8316) (SMFG) slipped 0.2%. Advantest Corp. (JP:6857) (ADTTF) shares were among the strongest performers, climbing 7%, with Kim Eng Securities noting a report of successful cost cutting at the chip-testing equipment maker.
- [By MARKETWATCH]
LOS ANGELES (MarketWatch) - Japanese stocks slipped at the open of trade Tuesday, as the Nikkei Stock Average pulled back from its 2.3% rally in the previous session. The Nikkei Stock Average (JP:NIK) shed 22 points, or 0.1%, to 15,628.07, and the broader Topix was flat at 1,255.14. Financial shares as well as some tech names were under pressure, including Trend Micro Inc. (JP:4704) (TMICY) , shares of which fell 2.8% following their 3% surge on Monday, and Sumitomo Mitsui Financial Group Inc. (JP:8316) (SMFG) as its stock lost 0.8%. In the currency market, the U.S. dollar held above the 楼103 level and the euro moved up toward 楼142.
No comments:
Post a Comment